• Vaxcyte EPS for the quarter ending December 31, 2024 was $-1.02, a 44.26% decline year-over-year.
• Vaxcyte 2024 annual EPS was $-3.8, a 8.21% decline from 2023.
• Vaxcyte 2023 annual EPS was $-4.14, a 20.35% increase from 2022.
• Vaxcyte 2022 annual EPS was $-3.44, a 78.24% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.